First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents.
Chan AM, Lowe BD, Cottingham AL, Van Eker D, Aytenfisu AH, Jones JW, MacKerell AD, Pearson RM, Fletcher S. 2026. First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents. ACS medicinal chemistry letters 17(1): 125-132. DOI: 10.1021/acsmedchemlett.5c00500